Alexey Semakov

Dr. Alexey Semakov

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Margarita NeganovaMargarita Neganova
Margarita Neganova
ASAlexey Semakov
Alexey Semakov
YAYulia Aleksandrova
Yulia Aleksandrova
EYEkaterina Yandulova
Ekaterina Yandulova
SPSergey Pukhov
Sergey Pukhov
SKSergey Klochkov
Sergey Klochkov
Anthracycline antitumor antibiotics are one of the promising classes of chemotherapeutic agents for cancer treatment. The main deterrent to their use is high toxicity to a healthy environment, including cumulative cardiotoxicity. In our work, bipharmacophore molecules containing in their structure a fragment of the known anthracycline antibiotics daunorubicin and doxorubicin and natural sesquiterpene lactones were obtained for the first time. When studying the biological activity of the synthesized compounds, it was found that with equal and, in some cases, higher cytotoxicity and glycolysis inhibition by anthracycline antibiotics conjugates with sesquiterpene lactones in comparison with doxo- and daunorubicin, a reduced damaging effect on the functioning of rat heart mitochondria was observed. The results obtained allow us to confirm the assumption that the chemical modification of the anthracycline antibiotics molecules doxo- and daunorubicin by natural sesquiterpene lactones can be a promising strategy for creating potential antitumor chemotherapeutic drugs with a pronounced cytotoxic effect on tumor cells and a reduced damaging effect on healthy cells of the human organism.

11 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Margarita NeganovaMargarita Neganova
Margarita Neganova
YAYulia Aleksandrova
Yulia Aleksandrova
ESE. V. Sharova
E. V. Sharova
ESEkaterina Smirnova
Ekaterina Smirnova
OAOleg Artyushin
Oleg Artyushin
VBValery K. K Brel
Valery K. K Brel
In recent years, researchers have often encountered the significance of the aberrant metabolism of tumor cells in the pathogenesis of malignant neoplasms. This phenomenon, known as the Warburg effect, provides a number of advantages in the survival of neoplastic cells, and its application is considered a potential strategy in the search for antitumor agents. With the aim of developing a promising platform for designing antitumor therapeutics, we synthesized a library of conjugates of 3,5-bis(arylidene)-4-piperidone and sesquiterpene lactones. To gain insight into the determinants of the biological activity of the prepared compounds, we showed that the conjugates of 3,5-bis(arylidene)-4-piperidone and sesquiterpene lactones, which are cytotoxic agents, demonstrate selective activity toward a number of tumor cell lines with glycolysis-inhibiting ability. Moreover, the results of molecular and in silico screening allowed us to identify these compounds as potential inhibitors of the pyruvate kinase M2 oncoprotein, which is the rate-determining enzyme of glycolysis. Thus, the results of our work indicate that the synthesized conjugates of 3,5-bis(arylidene)-4-piperidone and sesquiterpene lactones can be considered a promising platform for designing selective cytotoxic agents against the glycolysis process, which opens new possibilities for researchers involved in the search for antitumor therapeutics among compounds containing piperidone platforms.

1 September 2018 in Russian Journal of Bioorganic Chemistry
Verified
Journal Article
Closed access
PDF file
ASAlexey Semakov
Alexey Semakov
LAL. V. Anikina
L. V. Anikina
SAS. V. Afanasyeva
S. V. Afanasyeva
SPS. A. Pukhov
S. A. Pukhov
SKSergey Klochkov
Sergey Klochkov
The daunorubicin and doxorubicin anthracycline antibiotics were modified with the Inula heleniumL. sesquiterpene lactones (alantolactone, isoalantolactone, and alloalantolactone) and with their...

6 January 2025 in Molecules
Verified
Journal Article
Open access
PDF file
SPSergey Pukhov
Sergey Pukhov
ASAlexey Semakov
Alexey Semakov
NPNadezhda Pukaeva
Nadezhda Pukaeva
OKOlga Kukharskaia
Olga Kukharskaia
TITatyana Ivanova
Tatyana Ivanova
MKMichail Kukharsky
Michail Kukharsky
Artemisinin is a sesquiterpene lactone derived from the plant Artemisia annua L., renowned for its antimalarial activity. Based on this compound, various derivatives and analogues have been obtained that exhibit diverse biological activities, including clinically approved drugs. Recently, increasing evidence has highlighted the neuroprotective potential of artemisinin. In this study, we evaluated the effects of artemisinin on the viability of neuronal-like cells, including primary hippocampal neuronal cultures. Artemisinin exhibited a stimulating effect on SH-SY5Y and HEK-293 cells and enhanced the survival of primary neurons at low concentrations (1 µM). In contrast, artemisinin derivatives, such as dihydroartemisinin, anhydrodihydroartemisinin, and artemisitene, did not display similar stimulatory activity, suggesting that the intact lactone ring is crucial for this property. Furthermore, artemisinin demonstrated a protective effect against endoplasmic reticulum (ER) stress induced by the proteasome inhibitor MG132 in SH-SY5Y cells. However, it did not exhibit protective activity against oxidative stress induced by sodium arsenite. Additionally, artemisinin effectively inhibited the aggregation of mutated TDP-43 protein in transfected SH-SY5Y cells. These findings suggest that artemisinin exerts neuroprotective effects by targeting key molecular pathways associated with neurodegeneration, offering potential therapeutic insights for related conditions.

1 February 2024 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Margarita NeganovaMargarita Neganova
Margarita Neganova
JLJunQi Liu
JunQi Liu
YAYulia Aleksandrova
Yulia Aleksandrova
NVNatalia Vasilieva
Natalia Vasilieva
ASAlexey Semakov
Alexey Semakov
FRFan Ruitai
Fan Ruitai
Background: Sesquiterpene lactones are secondary plant metabolites with a wide variety of biological activities. The process of lactone conjugation to other pharmacophores can increase the efficacy and specificity of the conjugated agent effect on molecular targets in various diseases, including brain pathologies. Derivatives of biogenic indoles, including neurotransmitter serotonin, are of considerable interest as potential pharmacophores. Most of these compounds have neurotropic activity and, therefore, can be used in the synthesis of new drugs with neuroprotective properties. Aim: The aim of this experimental synthesis was to generate potential treatment agents for Alzheimer's disease using serotonin conjugated with natural sesquiterpene lactones. Methods: Three novel compounds were obtained via the Michael reaction and used for biological testing. The obtained conjugates demonstrated complex neuroprotective activities. Serotonin conjugated to isoalantolactone exhibited strong antioxidant and mitoprotective activities. Results: The agent was also found to inhibit β-site amyloid precursor protein cleaving enzyme 1 (BACE-1), prevent the aggregation of β-amyloid peptide 1-42, and protect SH-SY5Y neuroblastoma cells from neurotoxins such as glutamate and H2O2. In a transgenic animal model of Alzheimer's disease (5xFAD line), the conjugated agent restored declined cognitive functions and improved learning and memory. Conclusion: In conclusion, the obtained results indicate that serotonin conjugates to sesquiterpene lactones are promising agents for the treatment of symptoms associated with Alzheimer's disease.

22 October 2020 in Chemistry of plant raw material
Verified
Journal Article
Open access
PDF file
ASAlexey Semakov
Alexey Semakov
SKSergey Klochkov
Sergey Klochkov
Химия растительного сырья Научные журналы Алтайского государственного университета Научные журналы АлтГУ